Drug Research
Despite Rising Illness, Cambodian Pharma Sees Less Potential
Despite the increased prevalence of both communicable and non-communicable diseases in the nation, the commercial potential for medication manufacturers in Cambodia will remain restricted, according to a report by Fitch Solutions.
Based on the report, Cambodia's healthcare system is still...
Drug Research
Hemophilia Gene Cures From BioMarin, CSL Win ICER Support
Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their illness, even with a steep price tag of $2.5 million for each treatment. In a preliminary evidence report made...
Drug Research
WHO Demands More Study On People Living With Long COVID
The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously.
At least 17 million people in the 53 Member States of the WHO European Region may have encountered post-COVID-19...
News
Amid Chinese Pressure Biden To Boost US Biomanufacturing
The Biden Administration is previewing its next step in regaining American leadership in the pharmaceutical industry after focusing on the country's supply chains for pharmaceuticals last winter. On September 12th, President Joe Biden signed an executive order to advance...
News
How Have Surgical Instruments Developed Over Time?
The history of the medical field is a fascinating one. When the slightest thing can mean life or death in this field, looking back at how wrong the brightest minds of the world initially were makes for tense reading....
News
Pearly Penile Papules (PPP): Diagnosis, Treatment, And Prevention
Once you discover that you or your partner has pearly penile papules, it’s easy to feel like it’s the end of the world—this feeling has its roots in the fact that you have little to no knowledge about it....
Drug Research
$300mn Pledged By Novartis For European Biotherapeutics
The next-generation biotherapeutics will receive $300 million from Novartis, according to the company. To build a fully integrated, dedicated scientific environment to boost its capabilities and capacity for early technological development of biologics, the multi-year investment will be deployed...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read